TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 4 | -1 | -3 | 0 | 7 | 7 | -5 | 1 |
| S | %wins | 75 | 75 | 25 | 0 | 25 | 33 | 39 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/27/16 17:21 | 1/16/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Flakne Carla | MA | O | VP,Chief | S.a | -424 | 42.45 | 33 | -10 | -73 | 4 | D | 21 | -14 | -10 | 7 | -15 | -17 | -16 | -3 | 1 | -7 | -4 | 3 | 5 | |
9/2/15 16:52 | 8/31/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Flakne Carla | MA | O | VP,Chief | M.d | 0 | 0.00 | 33 | 3 | 130 | 6 | D | 64 | 41 | 11 | -2 | -2 | -5 | -4 | -3 | 0 | 1 | -4 | -20 | 4 | -25 |
4/16/15 09:53 | 3/16/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Flakne Carla | MA | O | VP,Chief | M.a | 330 | 38.79 | 22 | 9 | 4 | D | 90 | 47 | 34 | 19 | 7 | 5 | -1 | -1 | 0 | 1 | 1 | 4 | -8 | 1 | |
4/16/15 09:53 | 3/16/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Flakne Carla | MA | O | VP,Chief | S.a | -416 | 48.99 | 22 | -9 | -70 | 4 | D | 90 | 47 | 34 | 19 | 7 | 5 | -1 | -1 | 0 | 1 | 1 | 4 | -8 | 1 |
3/18/15 18:20 | 3/16/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Flakne Carla | MA | O | VP,Chief | M.d | 330 | 38.79 | 31 | 9 | 0 | D | 101 | 33 | 18 | 33 | 17 | 8 | 5 | 2 | -1 | -2 | 3 | 3 | 11 | 1 | |
3/18/15 18:20 | 3/16/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Flakne Carla | MA | O | VP,Chief | S.d | -416 | 48.99 | 31 | -9 | -100 | 0 | D | 101 | 33 | 18 | 33 | 17 | 8 | 5 | 2 | -1 | -2 | 3 | 3 | 11 | 1 |
1/20/15 16:10 | 1/16/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Flakne Carla | MA | O | VP,Chief | M.d | 232 | 23.15 | 26 | 10 | 4 | D | 106 | 9 | 11 | 17 | 10 | 15 | 13 | 3 | -2 | -3 | 1 | 16 | 20 | -18 | |
1/20/15 16:10 | 1/16/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Flakne Carla | MA | O | VP,Chief | S.d | -424 | 42.45 | 26 | -10 | -73 | 4 | D | 106 | 9 | 11 | 17 | 10 | 15 | 13 | 3 | -2 | -3 | 1 | 16 | 20 | -18 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |